Population Pharmacokinetics of Emtricitabine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates

被引:45
|
作者
Hirt, Deborah [1 ,2 ]
Urien, Saik [1 ,2 ]
Rey, Elisabeth [3 ]
Arrive, Elise [4 ]
Ekouevi, Didier K. [5 ]
Coffie, Patrick [5 ]
Leang, Sim Kruy [6 ]
Lalsab, Sarita [7 ]
Avit, Divine [5 ]
Nerrienet, Eric [8 ]
McIntyre, James [7 ]
Blanche, Stephane [9 ]
Dabis, Francois [4 ]
Treluyer, Jean-Marc [1 ,2 ,3 ]
机构
[1] Univ Paris 05, EA3620, Paris, France
[2] Hop Tarnier, AP HP, Unite Rech Clin, F-75006 Paris, France
[3] Univ Paris 05, Hop Cochin St Vincent de Paul, AP HP, Serv Pharmacol Clin, Paris, France
[4] Univ Victor Segalen, INSERM, ISPED, U897, Bordeaux, France
[5] ANRS Abidjan, Programme PAC CI, Abidjan, Cote Ivoire
[6] Hop Calmette, Serv Gynecol Obstet, Phnom Penh, Cambodia
[7] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit PHRU, Johannesburg, South Africa
[8] Inst Pasteur Cambodge, Phnom Penh, Cambodia
[9] Univ Paris 05, Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, Paris, France
关键词
DISOPROXIL FUMARATE; RESISTANCE; NEVIRAPINE; TENOFOVIR; QUANTIFICATION; PHARMACOLOGY;
D O I
10.1128/AAC.00860-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objectives of this study were to evaluate emtricitabine (FTC) pharmacokinetics in pregnant women and their neonates and to determine the optimal prophylactic dose for neonates after birth to prevent mother-to-child transmission of human immunodeficiency virus (HIV). A total of 38 HIV-infected pregnant women were administered tenofovir disoproxyl fumarate (300 mg)-FTC (200 mg) tablets-two tablets at the initiation of labor and one daily for 7 days postpartum. By pair, 11 maternal, one cord blood, and two neonatal FTC concentrations were measured using a high-performance liquid chromatography-tandem mass spectrometry validated method and analyzed by a population approach. Model and mean estimates (interpatient variability) were a two-compartment model for mothers, with an absorption rate constant of 0.54 h(-1) (61%), apparent elimination and intercompartmental clearances of 23.2 (17%) and 6.04 liters.h(-1), and apparent central and peripheral volumes of 127 and 237 liters, respectively; an effect compartment linked to maternal circulation for cord blood and a neonatal compartment disconnected, after delivery, with a 10.6-h half-life (30%). After the 400-mg FTC administration, the median population area under the concentration-time curve and the minimal and maximal plasma FTC concentrations in pregnant women were 14.3 mg.liter(-1).h and 1.68 and 0.076 mg/liter, respectively. At delivery, median (range) predicted maternal and cord blood FTC concentrations were, respectively, 1.16 (0.14 to 1.99) and 0.72 (0.05 to 1.19) mg.liter(-1). We concluded that the 400-mg FTC administration in pregnant women produces higher exposition than does the 200-mg administration in other adults, at steady state. FTC was shown to have good placental transfer (80%). Administering 1 mg FTC/kg as soon as possible after birth or 2 mg/kg 12 h after birth should produce neonatal concentrations comparable to the concentrations observed in adults.
引用
收藏
页码:1067 / 1073
页数:7
相关论文
共 50 条
  • [1] Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates
    Mirochnick, M
    Fenton, T
    Gagnier, P
    Pav, J
    Gwynne, M
    Siminski, S
    Sperling, RS
    Beckerman, K
    Jimenez, E
    Yogev, R
    Spector, SA
    Sullivan, JL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02): : 368 - 374
  • [2] Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring
    Moodley, J
    Moodley, D
    Pillay, K
    Coovadia, H
    Saba, J
    van Leeuwen, R
    Goodwin, C
    Harrigan, PR
    Moore, KHP
    Stone, C
    Plumb, R
    Johnson, MA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05): : 1327 - 1333
  • [3] Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children
    Luzuriaga, K
    Bryson, Y
    McSherry, G
    Robinson, J
    Stechenberg, B
    Scott, G
    Lamson, M
    Cort, S
    Sullivan, JL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 713 - 721
  • [4] Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infected women
    Mostad, SB
    Kreiss, JK
    Ryncarz, AJ
    Overbaugh, J
    Mandaliya, K
    Chohan, B
    Ndinya-Achola, J
    Bwayo, JJ
    Corey, L
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1999, 59 (04) : 469 - 473
  • [5] CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS
    CUNDY, KC
    BARDITCHCROVO, P
    WALKER, RE
    COLLIER, AC
    EBELING, D
    TOOLE, J
    JAFFE, HS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) : 2401 - 2405
  • [6] Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children
    Burger, DM
    van Rossum, AMC
    Hugen, PWH
    Suur, MH
    Hartwig, NG
    Geelen, SPM
    Scherpbier, HJ
    Hoetelmans, RMW
    Vulto, AG
    de Groot, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 701 - 705
  • [7] Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants
    Rodman, JH
    Flynn, PM
    Robbins, B
    Jimenez, E
    Bardeguez, AD
    Rodriguez, JF
    Blanchard, S
    Fridland, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06): : 1844 - 1850
  • [8] Population pharmacokinetics of emtricitabine (FTC) in HIV-1 infected pregnant women and their neonates (TEmAA -: ANRS 12109)
    Hirt, D.
    Urien, S.
    Rey, E.
    Blanche, S.
    Chaix, M. L.
    Rouzioux, C.
    Nerrienet, E.
    Mcintyre, J.
    Gray, G.
    Sim, K. Leang
    Ekouevi, D.
    Dabis, F.
    Treluyer, J. M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 87 - 87
  • [9] Infants of Human Immunodeficiency Virus Type 1-Infected Women in Rural South India
    Read, Jennifer S.
    Samuel, N. M.
    Srijayanth, Parameshwari
    Dharmarajan, Shoba
    Van Hook, Hannah M.
    Jacob, Mini
    Junankar, Viju
    Bethel, James
    Yu, Eunice
    Stoszek, Sonia K.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (01) : 14 - 17
  • [10] Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women
    Lisco, Andrea
    Barbierato, Massimo
    Fiore, Jose R.
    Gasperini, Paola
    Favia, Anna
    Volpe, Anna
    Chironna, Maria
    Pastore, Giuseppe
    Chieco-Bianchi, Luigi
    Calabro, Maria Luisa
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (11) : 3863 - 3871